Reply to: ‘NAFLD or comorbidities, that is the question’

por Ji, Dong, Zhang, Dawei, Lau, George
Publicado 2020

Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy

por Di Giorgio, Angelo, Nicastro, Emanuele, Speziani, Camilla, De Giorgio, Massimo, Pasulo, Luisa, Magro, Bianca, Fagiuoli, Stefano, D’ Antiga, Lorenzo
Publicado 2020

Lack of genetic evidence that fatty liver disease predisposes to COVID-19

por Valenti, Luca, Jamialahmadi, Oveis, Romeo, Stefano
Publicado 2020

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry

por Moon, Andrew M., Webb, Gwilym J., Aloman, Costica, Armstrong, Matthew J., Cargill, Tamsin, Dhanasekaran, Renumathy, Genescà, Joan, Gill, Upkar S., James, Theodore W., Jones, Patricia D., Marshall, Aileen, Mells, George, Perumalswami, Ponni V., Qi, Xiaolong, Su, Feng, Ufere, Nneka N., Barnes, Eleanor, Barritt, A. Sidney, Marjot, Thomas
Publicado 2020

An international multicenter study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise

por Chew, Claire Alexandra, Iyer, Shridhar Ganpathi, Kow, Alfred Wei Chieh, Madhavan, Krishnakumar, Wong, Andrea Sze Teng, Halazun, Karim J., Battula, Narendra, Scalera, Irene, Angelico, Roberta, Farid, Shahid, Buchholz, Bettina M., Rotellar, Fernando, Chan, Albert Chi-Yan, Kim, Jong Man, Wang, Chih-Chi, Pitchaimuthu, Maheswaran, Reddy, Mettu Srinivas, Soin, Arvinder Singh, Derosas, Carlos, Imventarza, Oscar, Isaac, John, Muiesan, Paolo, Mirza, Darius F., Bonney, Glenn Kunnath
Publicado 2020

Liver tests abnormalities in COVID-19: trick or treat?

por Vespa, Edoardo, Pugliese, Nicola, Piovani, Daniele, Capogreco, Antonio, Danese, Silvio, Aghemo, Alessio
Publicado 2020

Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2

por De Smet, Vincent, Verhulst, Stefaan, van Grunsven, Leo A.
Publicado 2020

SARS-CoV-2 related liver impairment – perception may not be the reality

por Philips, Cyriac Abby, Ahamed, Rizwan, Augustine, Philip
Publicado 2020

SARS-CoV-2: Is the liver merely a bystander to severe disease?

por Bangash, Mansoor N., Patel, Jaimin M., Parekh, Dhruv, Murphy, Nicholas, Brown, Rachel M., Elsharkawy, Ahmed M., Mehta, Gautam, Armstrong, Matthew J., Neil, Desley
Publicado 2020

High rates of 30-day mortality in patients with cirrhosis and COVID-19

por Iavarone, Massimo, D'Ambrosio, Roberta, Soria, Alessandro, Triolo, Michela, Pugliese, Nicola, Del Poggio, Paolo, Perricone, Giovanni, Massironi, Sara, Spinetti, Angiola, Buscarini, Elisabetta, Viganò, Mauro, Carriero, Canio, Fagiuoli, Stefano, Aghemo, Alessio, Belli, Luca S., Lucà, Martina, Pedaci, Marianna, Rimondi, Alessandro, Rumi, Maria Grazia, Invernizzi, Pietro, Bonfanti, Paolo, Lampertico, Pietro
Publicado 2020

COVID-19 and the liver

por Jothimani, Dinesh, Venugopal, Radhika, Abedin, Mohammed Forhad, Kaliamoorthy, Ilankumaran, Rela, Mohamed
Publicado 2020

Characteristics of pregnant patients with COVID-19 and liver injury

por Deng, Guangtong, Zeng, Furong, Zhang, Lijuan, Chen, Hui, Chen, Xiang, Yin, Mingzhu
Publicado 2020

The impact of COVID-19 on the clinical outcome of patients with cirrhosis deserves more attention and research

por Gao, Feng, Huang, Zhi-Ming
Publicado 2020

Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?

por Assante, Gabriella, Williams, Roger, Youngson, Neil Alexander
Publicado 2021

Letter regarding “High rates of 30-day mortality in patients with cirrhosis and COVID-19”

por Medhat, Mohammed A., El Kassas, Mohamed
Publicado 2020

Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis

por Fraga, Montserrat, Moradpour, Darius, Artru, Florent, Romailler, Elodie, Tschopp, Jonathan, Schneider, Antoine, Chtioui, Haithem, Neerman-Arbez, Marguerite, Casini, Alessandro, Alberio, Lorenzo, Sempoux, Christine
Publicado 2020

Reply to: Correspondence relating to “SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19”

por Wang, Yijin, Lu, Fengmin, Zhao, Jingmin
Publicado 2020

Reply to: “Liver tests abnormalities in COVID-19: trick or treat?”

por Cai, Qingxian, Xu, Lin, Chen, Jun
Publicado 2020

Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19

por Kroemer, Alexander, Khan, Khalid, Plassmeyer, Matthew, Alpan, Oral, Haseeb, M.A., Gupta, Raavi, Fishbein, Thomas M.
Publicado 2020

Interferon revisited: Peering behind the lines of antiviral defense

por Virzì, Alessia, Roca Suarez, Armando Andres, Lupberger, Joachim
Publicado 2020